Mylan Institutional LLC recalls Aloprim (allopurinol sodium) for Injection, 500 mg Single-Dose Vial, Rx only, Manufactured for: Mylan Institutional LLC,

Recalled May 27, 2020 · FDA recall D-1271-2020 · Mylan Institutional

Hazard

Discoloration: Out-of-specification results for appearance obtained during routine stability testing at the end of shelf-life for the parameters Appearance and Color of Solution. · FDA Class II

Units

3,010 vials

Sold at

Distributed Nationwide in the USA

Description

Discoloration: Out-of-specification results for appearance obtained during routine stability testing at the end of shelf-life for the parameters Appearance and Color of Solution.

Product

Aloprim (allopurinol sodium) for Injection, 500 mg Single-Dose Vial, Rx only, Manufactured for: Mylan Institutional LLC, Rockford, IL 61103 USA. NDC: 67457-187-50

Manufacturer(s)

Mylan Institutional LLC

Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →